On Drugs

Share this post

The On Drugs Library

ondrugs.substack.com

The On Drugs Library

Jul 8, 2022
Share this post

The On Drugs Library

ondrugs.substack.com

As our About page explains, we take the subscription fees and pour it back into this Newsletter to generate high quality, original content. Nonetheless, consistent with the purpose of the newsletter, most content published is free. We are currently using subscription revenue to fund archival retrievals, FOIA requests, and other content purchases for stories. In the interests of full transparency, we’re showing you the receipts.

Our first wave of FOIA requests and archival requests are beginning to bear fruit. So it is time to introduce the On Drugs Library. This Library contains the documents we obtain. There is some interesting (and non-interesting) items in here that we just don’t have the time to write about.

We continue to make archival requests and FOIA requests to write new stories and add documents to this library. You can help support us generating original content and grow this library by becoming a paid subscriber.

(Updated 9/28/22)

Benzodiazepines Hearings

Description: Response to FOIA request to FDA for “all transcripts, exhibits, and agency decisions or guidance that relate to the Part 15 public hearing held on September 11, 1997. in "Benzodiazepines and Related Substances; Criteria for Scheduling Recommendations Under the Controlled Substance Act; Notice of Public Hearing Modification" described at 62 Fed. Reg. 33418 and 62 Fed. Reg. 45667.”

DEA Presentation and Poster re: Scheduling

Description: Two files received from a FOIA request to DEA.

  • Carbonaro, TM (2021) Evaluating Drug Abuse Liability: Applying Pharmacology Data to Drug Scheduling Actions (seminar presentation); and

  • Carbonaro, TM, Tella SR, Boos, TL (2021) The Controlled Substances Act Regulations on Schedule I Researcher Registrations and the Need to Investigate New Substances of Abuse.

Five Tryptamines

Description: Hundreds of documents filed in the Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 5-methoxy-N,N-diethyltryptamine (5-MeO-DET), and N,N-diisopropyltryptamine (DiPT) in Schedule I (“Five Tryptamines”) matter.

  1. Case Filings

  2. Witness Statements

    • Jason Wallach

    • Michael Coyle

    • David Nutt

    • Shane Pennington

    • Dillan DiNardo

    • Andrew Chadeayne

    • Lynnette Averill

    • Theresa Carbonaro

    • Daniel Riddle

    • David Heldreth

    • Matt Baggott (correction)

    • Jeffrey Becker

    • Adam Halberstadt (letter)

    • Brett Giroir

    • Hamilton Morris

  3. Government Exhibits

    • Drug Discrimination Studies and Assays

    • 2008 DEA Data Report

    • NFLIS Drug Data

    • Erowid Reports

    • E-mails re: Updated FDA Determination

The Bright Green Files

Description: Documents obtained from a New Mexico open records request for court filings in the two lawsuits involving Bright Green.

  1. Papers from Bright Green v. Jerry Capussi, D1333CV202000252

  2. Papers from Bright Green v. John Fikany, D1333CV202000231

  3. Transcript of an August 2017 Shareholder’s Meeting of Sunnyland Farms, Inc. (Part 1)

  4. Transcript of an August 2017 Shareholder’s Meeting of Sunnyland Farms, Inc. (Part 2)

The John Dean Files

Description: Archival documents obtained from the Nixon Archives belonging to John Dean that relate to drug policy, including the formation of the CSA.

  1. Vol. 29-1

  2. Vol. 29-2

    • Political cartoon

    • List of BNDD foreign training schools

    • Letter from Montgomery County (Md.) Council Concerning the Rape of Our People by Degenerative Drugs

    • August 9, 1972 Memorandum relating to a legal dispute as to NORML Petition to Decontrol Marihuana or Place it in Schedule V of CSA (enclosing August 7, 1972 memorandum)

    • August 4, 1972 Memorandum relating to NORML Petition to Remove Marihuana from Control or Place in Lowest Schedule

    • August 4, 1972 Memorandum on proposed BNDD Action on Petition to Reschedule Marihuana

    • August 3, 1972 Memorandum on Petition to Reschedule Marihuana - BNDD Proposed Action

  3. Vol. 29-3

    • Treaty Obligations of the United States Relating to Marihuana

    • July 26, 1972 Decision of Department of Justice refusing to accept Petition to Remove Marihuana from Control or in the Alternative to Control Marihuana in Schedule V

    • Single Convention of Narcotic Drugs 1961

  4. Vol. 29-4

    • May 18, 1972 NORML Petition to Reschedule Marihuana.

  5. Vol. 29-5

    • Feb. 2, 1973 newspaper article and handwritten speech notes for graduation.

    • December 20, 1971 letter to John Dean from Warren Iliff

    • List of BNDD training schools

  6. Vol. 29-6

    • Proposed speech at the graduation of the Narcotics Course being conducted by the US Bureau of Narcotics and Dangerous Drugs

    • October 7, 1970 letter from Kenly Webster enclosing materials relating to drug abuse in the armed services.

  7. Vol. 29-7

    • October 14, 1970 statement by Arthur Allen re: Drug Abuse by members of the Armed Forces

  8. Vol. 29-8

    • September 16, 1970 response to request for assistance regarding “Operation Awareness", a drug treatment program at Fort Bragg

    • July 24, 1970 Report of Task Group Convened to Recommend Appropriate Revisions to DoD Policy on Drug Abuse

  9. Vol. 29-9

    • Note from Mike [Sonnenreich?] to Dean enclosing views of a “Radic-Lib”

    • March 15, 1972 Memorandum from Perry Rivkind to John Dean with BNDD’s revised schedule of foreign training schools

    • November 10, 1971 Memorandum from Liddy to Erlichman entitled "“Breaking the Connection” on drug dealers, and handwritten notes

    • Correspondence from 1971

  10. Vol. 29-10

    • July 13, 1971 memorandum re: Opportunities for Private Sector Involvement in Combatting Drug Problem and materials relating to private sector investment

    • Program materials for the preparation of proposals for drug abuse education projects.

  11. Vol. 29-11

    • July 19, 1971 Memorandum to John Dean re: Private Sector Involvement in Combatting Drug Problem

    • June 24, 1971 Memorandum from BNDD re: Private Sector Involvement in Combatting Drug Problem

    • 1970s brochures on combatting drug abuse and drug abuse prevention

  12. Vol. 29-12

    • June 4, 1971 letter from Edwards to Dean regarding National Drug Education Institute for US Dependent Schools in the European Area

    • May-June 1971 BNDD Bulletin

    • November 12, 1970 Address at the International Symposium on Drug Abuse

    • November 16, 1970 Memorandum re: Suppression of the Sale of Heroin within the United States

  13. Vol. 29-13

    • Assortment of documents regarding War on Heroin

    • December 17, 1970 Memo from Sonnenreich o Johnson re: Jurisdictional Problems in the South Pacific

    • Uniform Controlled Substances Act

    • Articles regarding Japan Drug War

    • Correspondence regarding drug use in Vietnam

  14. Vol. 29-14

    • 1970 articles regarding heroin use into the US

    • October 27, 1970 remarks of the President upon signing of the CSA

    • September 30, 1970 Memorandum from Stanley Ebner to Wallace Johnson regarding Delays in Legislative Process on Drug Control Bill.

    • October 21, 1970 letter from Kleindienst summarizing House version of drug control bill.

  15. Vol. 29-15

    • October 22, 1970 draft letter to Wallace regarding DOD training

    • September 21, 1970 letter from President of American Public Health Association

    • Papers relating to 10-Week school at the BNDD National Training Institute

    • Statement by the President on Signing the Comprehensive Drug Abuse Prevention and Control Act of 1970

    • March 11, 1970 Statement by the President

    • July 14, 1969 Statement by the President

  16. Vol. 29-16

    • September 17, 1970 Memorandum for Magruder regarding placing Librium-Valium article

    • BNDD Military School itinerary

    • Special agent training graduation materials

    • Letter from Congressman Wiggins to Dean regarding amendment to drug control bill regarding amphetamines

    • Papers on marijuana with handwritten notes, including papers by Andrew Weil

  17. Vol. 29-17

    • Papers on marijuana

    • September 10, 1970 Memorandum from Wallace Johnson regarding status of drug bill

    • September 10, 1970 Memorandum by John Dean for Attorney Genearl regarding Drug Bill

  18. Vol. 30-1

    • No Knock and Nonsense, an Alleged Constitutional Problem

    • August 18, 1970 Memo from Sonnenreich to Dean summarizing Drug Abuse Bill

    • August 21, 1970 NY Post Article

    • Address by Ingersoll to Special Agent Class #10 and handwritten notes

    • April 20, 1970 Letter from Hoffman-La Roche enclosing Congressional Record

    • Bureau of Dangerous Drugs, Part 300.

  19. Vol. 30-2

    • December 21, 1970 letter from Sonnenreich to Dean enclosing floor debates on the Drug Bill

  20. Vol. 30-3

    • February 9. 1970 Memorandum from Sonnenreich to Dean including FDC reports describing legislative hearings.

    • April 24, 1970 Memorandum to John Dean from Wayman Sherrer re: Comments concerning proposed Uniform Controlled Dangerous Substances Act

    • April 17, 1970 Memorandum regarding proposed changes to Senate drug abuse bill

    • Letter from Eugene T. Rossides to Rep. Silvio Conte

    • April 19, 1970 Letter from Deputy Attorney General Kleindiest to Director of Budget Robert Mayo regarding drug abuse bill

    • S. 3246 “Controlled Dangerous Substances Act of 1969” summary

    • April 17, 1970 Memorandum for Bud Krogh

    • March 24, 1970 Memorandum from Stanley Ebner to John Dean regarding drug abuse bill

  21. Vol. 30-4

    • May 21, 1969 Memorandum from Sonnenreich to Dean regarding comments received from Malincrodkt Chemical Company

    • June 9, 1969 Memorandum from Michael Sonnenreich to John Dean discussing Congressman Poff’s letter to the Attorney General relating to drug bill

    • May 21, 1969 letter from Richard Poff to Attorney General Mitchell regarding drug bill

    • June 6, 1969 letter to John Dean from Louis Nichols

    • Summary of HEW Staff Views of Justice Department Draft Bill

    • June 13, 1969 letter from Lou Frey to John Dean enclosing chart.

    • April 24, 1969 letter from John Wells to John Mitchell enclosing bill provisions

    • March 20, 1969 letter from Wells to Mitchell regarding bill provisions and attached memorandum from Hoffman-La Roche regarding Librium and Valium

  22. Vol. 30-5

    • Leary v. United States opinion

    • March 20, 1969 letter from Wells to Mitchell regarding bill provisions and attached memorandum from Hoffman-La Roche regarding Librium and Valium

  23. Vol. 30-6

    • July 2, 1969 Memorandum to the Attorney General from John Dean

    • March 13, 1969 Memorandum from Will Wilson to the Attorney General re: drug bill

    • May 7, 1969 Memorandum from Michael Sonnenreich to John Dean re: drug bill

    • June 13, 1969 letter from Corber to Revercomb enclosing materials on importation of narcotics and antitrust issues

  24. Vol. 30-7

    • December 4, 1969 memorandum from Hugh Durham to John Dean re: Amendment to Marihuana Tax Act to cure Leary Defect

    • May 23, 1969 note regarding Senator Cook and establishment of a National Narcotics and Dangerous Drug Institute, including discussion of Mitch McConnell, aide to Senator Cook

    • October 18, 1969 letter from Sen. Mathias to Pres. Nixon

    • September 24, 1969 correspondence from Donald Miller to John Dean re: Automobile forfeiture policy.

    • September 22, 1969 letter from William Ryan to John McCarren re: Regulations regarding civil forfeiture

    • January 16, 1969 Memorandum re: Sec. 409 of Controlled Dangerous Substances Act of 1969

    • June 24, 1969 Memorandum from Michael Sonnenreich to John Dean re: Recommendations of Treasury Department on Controlled Substances Dangerous Substances Act bill

    • August 26, 1969 Memorandum from Michael Sonnenreich to John Dean re: committee to investigate marihuana

  25. Vol. 30-8

    • January 25, 1970 handwritten note about legalizing marijuana

    • News article

    • January 28, 1970 letter from John Dean to Lamar Alexander forwarding draft letter

    • February 3, 1970 Memorandum from Robert Blakey to Michael Sonnenreich re: “preponderance of the evidence”

    • FDC Reports

    • May 14, 1970 letter from John Dean to :James Menger answering questions about drug bill

    • Various letters from John Dean

    • April 17, 1970 Memorandum from Bud Krogh to John Dean regarding Congressional Conference on Drugs

    • April 28, 1970 Memorandum from Michael Sonnenreich to John Dean regarding AMA’s objections to drug bill

    • May 4, 1970 Memorandum from John Dean to Congressman Rogers re: BOP and Narcotic Addict Rehabilitation Act of 1966.

    • Memorandum to the Attorney General on the need for one codified narcotic and dangerous drug law.

    • April 8, 1970 Memorandum from Michael Sonnenreich to John Dean with proposed changes to drug bill

  26. Vol. 30-9

    • June 15, 1970 press release on narcotics from Congressman Poff

    • May 28, 1970 memo re: bill on mandatory civil commitment for narcotic addicts.

    • Memorandum from Attorney General John Mitchell for Erlichman

    • August 3, 1970 FDC reports

    • June 13, 1969 Letter from Paul Eggers re: Marihuana and taxes

    • April 18, 1969 Memorandum to Kenneth Cole from Eugene Rossides re: Message on Narcotics and Dangerous drugs

    • April 18, 1969 Memorandum from A.E. Weatherbes to Eugene Rossides re: Removal of Narcotics Agents from Career Civil Service

    • April 18, 1969 Memorandum from Paul Volcker re: Message to Congress on Narcotics and Dangerous Drugs

    • September 17, 1968 Statement from Richard Nixon

    • April 15, 1969 Letter from Paul Eggers re: drug Bill

  27. Vol. 30-10

    1. April 18, 1969 Memorandum for Kenneth Cole

    2. April 18, 1969 Memorandum for President

    3. April 14, 1969 Draft Address to Congress

    4. April 15, 1969 letter from Paul Eggers and Treasury Department Memorandum

    5. April 29, 1969 Memorandum to John Dean from Eugene Rossides

    6. April 18, 1969 Memorandum to Kenneth Cole from Paul Volcker

    7. September 17, 1968 Speech of Richard Nixon

  28. Vol. 30-11

    1. June 4, 1969 Memorandum from Patrick Gray to Hugh Durham

    2. May 1, 1969 letter from Theodore Ellenbogen to John Dean enclosing letter

    3. April 30, 1969 Memorandum from from Theodore Ellenbogen to John Dean

  29. Vol. 30-12

    1. April 12, 1969 letter from Robert Finch re: draft drug abuse bill

    2. Staff Memorandum on Justice Department draft of drug abuse bill

    3. April 22, 1970 letter from Sen. Thomas Dodd to Rep. John Jarman

  30. Vol. 30-13

    1. News releases from Sen. Thomas Dodd

    2. January 26, 1970 Memorandum from ACLU on drug bill

    3. Meprobamate outline

    4. Memorandum from Ingersoll to Mitchell re: Meprobamate

    5. July 2, 1970 Memorandum from Sonnenreich to Ingersoll re: legal problems in staying control of Meprobamate

  31. Vol. 30-14

    • Papers from Meprobamate proceedings

    • July 1, 1970 Memorandum from Sonnenreich regarding Meprobamate proceedings

    • Memorandum from John Ingersoll to Roger Egeberg re: Staff revision of drug bill

    • Pages from FDC Reports

    • June 20, 1970 Memorandum from Ellenbogen to Black

  32. Vol. 30-15

    • Draft Attorney General remarks for White House Drug Conference

    • March 30, 1970 Memorandum from Jeb Magruder to Ziegler re: Meeting of TV Producers on Drug Abuse to try to get television networks to incorporate anti-drug themes into programming and agendas

    • March 11, 1970 Drug Abuse Program fact sheet

  33. Vol. 30-16

    • Jeb Magruder’s resume

    • Draft Attorney General remarks for White House Drug Conference

The Robert Randall Files

Special thanks to Perkins Coie for helping us obtain these files in the AIMS v. DEA litigation.

Description: Archival documents from Robert Randall located at the University of Wisconsin that relates to marijuana rescheduling and the federal marijuana Compassionate Access IND program where select patients got marijuana from the federal government for medical use.

  1. Box 1 F15

    • Reply Brief in the Matter of Marijuana Rescheduling Petition, Dkt. 86-22

    • Hearing Transcript from in the Matter of Marijuana Rescheduling Petition, Dkt. 86-22’

  2. Box 1 F16

    • Testimony of Robert Randall in Public Hearing on Marijuana, Dkt. 82N-0162

    • Affidavit of Ben S. Fine, M.D.

    • Affidavit of Robert S. Helper, M.D.

    • March 22, 1976 letter from Gary Diamond, M.D. to Ben S. Fine, M.D.

    • Daily Washington Law Reporter

    • Affidavit John C. Merrit, M.D.

    • Affidavit of Robert Randall

    • News articles, for example, “America’s only legal pot smoker”

  3. Box 1 F17

    • Alliance for Cannabis Therapeutics brochure

    • August 9, 1972 John Ingersoll

    • Marijuana: Medicine or Menace?

    • MARS: Marijuana and AIDS Research Service A Project of The Alliance for Cannabis Therapeutics & Richard J. Dennis

    • Marijuana & AIDS: Pot, Poltiics & PWAs in America

    • ACT News items

    • March 1, 1991 Chicago Sun-Times article

    • Legal Access to Marijuana: The Compassionate IND Application

    • 1990s News Articles

  4. Box 1 F21

    • Affidavit of Robert S. Helper, M.D.

    • Marijuana Deals, Cancer Victims and Questions of Logic article

    • IND for Delta-9-THC dated August 28, 1978

    • Tetrohydrocannabinol: From Pot to Prescription?

    • Minutes of May 9, 1978 Meeting on the Current Status of Research with THC and Nabilone

    • June 28, 1983 Press Release re: State AGs Support Medical Use of Marijuana

    • August 24, 1983 Letter from Stewart McKinney to Bruce Chabner re: THC and marijuana research.

    • Paper describing controlled trial of THC and marijuana as antiemetics

  5. Box 2 F7 PRT1

    • April 4, 1984 Memorandum on ACT/Marijuana Legislation cases

    • April 23, 1983 Memorandum re: ACT lobbying efforts

    • April 26, 1984 Memorandum re: taking ACT as pro bono client

    • July 1, 1980 letter from Robert Randall to Jim Young

    • September 5, 1980 Memorandum re: August 25, 1980 meeting re: ACT

    • Memorandum from James Young to Robert Randall and Alice O’Leary re: Regulatory Barriers to the Availability of Marijuana for Therapeutic Use

    • August 15, 1980 Memorandum from Carole Mitchell to Jim Young re: Therapeutic Uses of Marijuana Under International Drug Control

    • June 15, 1983 Memorandum from Doug Herbert re: ACT

  6. Box 2 F7 PRT2

    1. Draft corporate papers for AMAC

    2. Randall Meeting Agenda

    3. Correspondence relating to corporate formation

    4. March 3, 1980 Memorandum re: Pro Bono Project

    5. March 6, 1980 re: Pro Bono Representation of Randall Organization

    6. February 27, 1980 Memorandum re: February 27, 1980

    7. Alliance for Cannabis Therapeutics - Statement of Purpose

  7. Box 2 F8_1

    • May 6, 1983 letter from Robert Randall to Steptoe & Johnson

    • July 15, 1982 Memorandum re: ACT Schedule

    • December 2, 1978 speech entitled Litigation for Medical Access to Marijuana: Federal Considerations discussing Compassionate IND

    • August 29, 1978 letter from Peter Meyers to Tom Collier

    • June 30, 1978 letter from Tom Collier to Peter Meyers

    • June 30, 1978 Memo to File re: Potential Actions Concerning the Therapeutic Use of Marijuana

    • July 30, 1982 memo from Mark Hersh to Doug Herbert and Jim Young re: Challenging the FDA’s Position that an Approved NDA is a Prerequisite to the Rescheduling of a Schedule I drug and Addendum

    • June 22, 1982 Memorandum from Doug Herbert re: ACT/McKinney Speech to National Council on Drugs

    • List of those appointed to Council on Drugs committee on medical marijuana

    • October 11, 1980 summary from Alice O’Leary re: Federal Legislation

    • August 1, 1980 letter from Bob Randall to Jim Young re: Issue Evolution

    • Memorandum in support of Bill to Provide for Therapeutic Use of Marijuana in Situations involving Life or Sense-Threatening Illness

    • July 15, 1983 Memorandum from Doug Herbert re: ACT and legislative efforts

    • May 6, 1983 letter from Jane McGraw to Robert Randall enclosing memo

    • December 12, 1981 letter from Jim Young to Dr. Tocus re: Randall’s receipt of marijuana from FDA.

    • December 7, 1981 letter from DEA Acting Administrator Francis McMullen from DEA re: marijuana’s stocking in retail pharmacies

    • December 28, 1981 letter from Bob Randall to Jim Young

    • December 28, 1981 letter from DEA Chief Compliance Ronald Buzzo to Jim Young

    • November 11, 1981 letter from Jim Young to Ronald Buzzo

    • November 2, 1981 letter from Jim Young to Dr. Joseph Gallelli (NIH)

    • November 12, 1981 letter from Dale Morton to Jim Young

    • December 19, 1980 letter from Robert Randall to Jim Young re: Possible Supply Alterations

    • February 5, 1981 letter from Jim Young to Robert Randall, Alice O’Leary

    • February 2, 1981 letter from Jim Young to Robert Randall

    • January 28, 1981 letter from Richard Hawks (HHS) to John Bryston

    • March 9, 1981 letter form Jim Young to Richard Hawks

    • January 9, 1981 letter from Robert Willette (HHS) to John Ishiter

    • February 24, 1981 letter from Robert Randall to Jim Young re: NIDA contamination

    • February 24, 1981 letter from Robert Randall to Richard North

    • Memo from Robert Randall to Tom Collier re: Proposed Testimony Controlled Substance Advisory Committee and Chronology

    • Letter from Robert Randall re: Appreciation

    • February 20, 1978 letters from Robert Randall to Margaret Standish (Playboy) and Keith Stroup (NORML)

    • March 13, 1978 Randall outline and memorandum to file on judicial relief

    • March 1, 1978 Memorandum from Tom Collier to John Bryson re: Coordination of Randall Facts

  8. M2014 074 Box 1 F6

    • IND Glaucoma protocol for marijuana

    • Glaucoma and Marijuana Therapy prepared by ACT

    • Legal Access to Marijuana: The Compassionate IND Application

    • IND Forms for obtaining marijuana

    • August 13, 1991 Memorandum from John Tobin to Lynn Sargent re: Preliminary Evaluation of Compassionate IND Issues enclosing

    • Draft August 12, 1991 memo from Kate Jones to Lynn Sargent and Steve Davidson re: Disruption of Supply of Marijuana for Compassionate IND Program

  9. M2014 074 Box 1 F15 PRT1

    • Transcript of the testimony of Mahmoud ElSohly in People v. Charles Hamilton re: University of Mississippi marijuana

    • May/June 1988 Drug Law Report article “Challenging Marijuana’s Schedule I Classification” by Robert Randall

    • GAO Investigation Request re: Marijuana

    • Amended Findings of Fact and Conclusions of Law in In the Matter of Marijuana Rescheduling Petition, Docket No. 86-22

    • Memorandum from In the Matter of Marijuana Rescheduling Petition, Docket No. 86-22 on Impact of MDMA Scheduling on these Proceedings

  10. M2014-074 b3 23 part 1

    • January 7, 1981 Press Release re: Marijuana Supply Shortage Disrupts California Medical Program

    • 1981 correspondence with congressmembers re: medical marijuana and pending legislation (dozens of letters)

  11. M2014-074 b3 23 part 2

    • 1981 correspondence with congressmembers re: medical marijuana and pending legislation (dozens of letters)

  12. M2014-074 b3 f24

    • October 1981 commonly asked questions about pending legislation to legalize medical marijuana

    • September 16, 1981 Congressional Record

    • February 14, 1983 letter from Stewart McKinney to Newt Gingrich regarding Gingrich withdrawing support for medical marijuana bill.

  13. M2014-074 b4 f2 part 1

    • March 18, 1992 Memorandum from Assistant Secretary of Health Mason re: Therapeutic Marijuana — STATUS reflecting policy decision to terminate IND program

    • National Institute of Dental Research Factsheet on the Use of Marijuana for Chronic Pain

    • National Institute of Neurological Disorders and Stroke Factsheet on the Therapeutic Use of Marijuana for MS

    • National Institute on Allergy and Infectious Diseases Factsheet on the Therapeutic Use of Marijuana for Patients with HIV-Wasting Syndrome

    • Marijuana for Chemotherapy-Induced Nausea and Vomiting

    • National Eye Institute Factsheet on the Therapeutic Use of Marijuana for Glaucoma

    • April 1, 1992 Memorandum from Director of NIAID to James Mason re: termination of Therapeutic Marijuana Program and Marinol and clinical trial protocol.

    • Press clippings re: McKinney bill to legalize medical marijuana

    • September 1, 1989 letter from Frank Stillwell to John Lawn re: In the Matter of Marijuana Rescheduling

    • September 22, 1988 letter from Robert Randall to ACT Witnesses re: favorable decision from DEA ALJ

  14. M2014-074 b4 f2 part 2

    • Grant awards for research relating to THC or marijuana

    • National Eye Institute Statement on the Therapeutic Use of Glaucoma

    • January 1987 Annual Report to FDA on THC

    • March 4, 1992 letter from Stephen Greene (DEA) to James Mason (HHS) re: marijuana rescheduling

    • January 31, 1992 letter from James Mason (HHS) re: Therapeutic use of marijuana — Decision

    • March19, 1992 note to Dr. Mason re: Marijuana letter to Pending and Clinical Hold Applications

    • April 23, 1992 Memorandum from Dan Spyker to Francesca Cook re: Letters to IND Investigators Receiving Marijuana enclosing letters explaining ending of IND program

    • May 18, 1992 letter from Louis Sullivan to Rep. Henry Waxman re: marijuana for therapeutic purposes

    • A Handbook on Drug and Alcohol Abuse

    • Drugs of Abuse

    • Single Convention of Narcotics Drugs

    • Notice of Withdrawal of Motion for Temporary Restraining Order in Randall v. USA

    • Answer to question “[f]or what conditions has the medical use of marijuana been allowed in the U.S.?”

    • March 23, 1992 letter from Rep. Waxman to Louis Sullivan (HHS)

  15. M2014-074 b4 f3

    • 1983 adverse drug reaction reports relating to THC produced through FOIA

    • Group C Guidelines for the use of THC for Nausea and Vomiting and Informed Consent

    • April 1985 Annual Report to FDA on THC

    • March 1984 Annual Report to FDA on THC

    • March 1982 Annual Report to FDA on THC

    • FOIA requests from ACT and NORML

    • Article on cannabinoids and glaucoma

The NIDA Contracts

Description: Documents obtained the University of Mississippi under Mississippi open records laws detailing the contractual relationship between the University of Mississippi and NIDA to cultivate marijuana for research between 2010 and 2020. These contracts contain, among other items, the Statements of Work, the size of the contract.

  1. Part 1

  2. Part 2

The DEA Seed Letter

Description: Shane asks DEA if marijuana seeds or other parts of a marijuana plant having less than .3% THC by dry weight are controlled under the CSA. DEA’s answer? No.

NIDA Drug Discrimination Study Contracts

Description: Documents obtained from a FOIA for interagency agreements among NIDA, DEA, DOJ relating to drug discrimination studies.”

Share this post

The On Drugs Library

ondrugs.substack.com
Comments
TopNewCommunity

No posts

Ready for more?

© 2023 Matt and/or Shane
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing